Clinical Trial

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age

Study acronym: RhinoPOCRCT
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-05; most recent amendment 2025-02-11.
Status change: Not Yet Recruiting → Recruiting 2022-11-04
Trial Details
NCT Number NCT05444699
Lead Sponsor University of Oulu
Conditions Bronchiolitis Acute Viral
Enrollment 210 participants
Start Date 2022-10-11
Primary Completion 2026-12 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-02-13